Advanced search
Publication Cover
Expert Review of Vaccines Volume 1, 2002 - Issue 4
Submit an article Journal homepage
34
Views
25
CrossRef citations to date
0
Altmetric
Review

Current advances in antifertility vaccines for fertility control and noncontraceptive applications

Valerie A Ferro Department of Immunology, University of Strathclyde, SIBS Building, 27 Taylor Street, Glasgow G4 ONR, UK. [email protected]
Pages 443-452 | Published online: 09 Jan 2014

References

  • Baird DT Overview of advances in contraception. BE Med. Bull 56(3), 704–716 (2000).
  • Delves PJ, Lund T, Roitt IM. Future prospects for vaccines to control fertility. Trends Immunol 23(4), 220–221 (2002).
  • Nelson A. Contraceptive update Y2K: need for contraception and new contraceptive options. Clin. Cornerstone 3(1), 48–62 (2000).
  • Darroch JE. Adolescent pregnancy trends and demographics. CI.117: Womens Health Rep. 1(2), 102–110 (2001).
  • Bradley MP, Eade J, Penhale J, Bird P. Vaccines for fertility regulation of wild and domestic species. I Biotechnol 73(2-3), 91–101 (1999).
  • Stohr K, Meslin, FX. Zoonoses and fertility control in wildlife - requirements for vaccines. Reprod. Fertil Dev 9(1), 149–155 (1997).
  • Zeng XY, Turkstra JA, Meloen RII et al Active immunization against gonadotrophin-releasing hormone in Chinese male pigs: effects of dose on antibody titer, hormone levels and sexual development. Anim. Reprod. Sc]. 70(3–4), 223–233 (2002).
  • Kiyama Z, Adams TE, Hess BW, Riley ML, Murdoch WJ, Moss GE. Gonadal function, sexual behavior, feedlot performance and carcass traits of ram lambs actively immunized against GnRII. J: Anim. Sc]. 78(9), 2237–2243 (2000).
  • Greer J, Rozell T Development and use of recombinant gonadotropin-releasing hormone vaccines to sterilize cattle: a review. Kansas State University Dairy Day Report of Progress 792,32–34 (1997).
  • Delves PJ, Lund T, Roitt IM. Antifertility vaccines. Trends Immunol 23 (4), 213 — 219 (2002).
  • Talwar GP Vaccines and passive immunological approaches for the control of fertility and hormone-dependent cancers. Immunol Rev 171,173–192 (1999).
  • Stevens VC. Antifertility vaccines. In: Handbook of Experimental Pharmacology Perlmann P, Wigzell H (Eds), Springer -Verlag, 443–461 (1999).
  • Richter J, Sexton S. In: Vaccination Against Pregnang,: Miracle or Menace. Spinifex Press, Melbourne, Australia (1996).
  • Moudgal NR, Murthy GS, Prasanna Kumar KM et al Responsiveness of human male volunteers to immunization with ovine follicle stimulating hormone vaccine: results of a pilot study. Hum. Reprod 12(3), 457–463 (1997).
  • Moudgal NR, Dighe RR. Is FSH-based contraceptive vaccine a feasible proposition for the human male? In: Reproductive Immunology Gupta SD (Ed.), Narosa Press, New Delhi, India, (1999).
  • Sairam MR, Krishnamurthy H. The role of follicle-stimulating hormone in spermatogenesis: lessons from knockout animal models. Arch. Med. Res. 32(6), 601–608 (2001).
  • Ferro VA, Stimson WH. Fertility disrupting potential of synthetic peptides derived from the l subunit of follicle stimulating hormone. Am J. Repod hum. 40(3), 187–197 (1998).
  • Westhoff WE, Slootstra JW, Puijk WC et al. In vitro inhibition of the biological activity of follicle-stimulating hormone by antipeptide antisera representing the human follicle-stimulating hormone 13 subunit sequence 33–53. Biol. Repmd. 56(2), 460–468 (1997).
  • Ferro VA, Stimson WH. Antigonadotropin releasing hormone vaccines and their potential use in the treatment of hormone responsive cancers. BioDrugs 12(1), 1–12 (1999).
  • Simms MS, Scholfield DP, Jacobs E et al AntiGnRII antibodies can induce castratelevels of testosterone in patients with advanced prostate cancer. BE J. Cancer 83(4), 443–446 (2000).
  • Jeyakumar M, Suresh R, Krishnamurthy HN, Moudgal NR. Changes in testicular function following specific deprivation of LH in the adult male rabbit. J. Endocrinol 147(1), 111–120 (1995).
  • Kirsch RD, Beale D, He M, Corper AL, Krawinkel-Brenig U, Taussig MJ. Anti-anti-idiotypic (Ab3) antibodies that bind progesterone-11 alpha-bovine serum albumin differ in their combining sites from antibodies raised directly against the antigen. hnmunology100(2), 152–164 (2000).
  • Kishi H, Okada T, Kawazu et al. Effects of passive immunization against oestradio1-17 beta and inhibin on the secretion of gonadotrophin in the cylic golden hamster (Mesocricetus auratu, . Reprod Perth. Dev 9(4), 447–453 (1997).
  • Auclair D, Sowerbutts SF, Setchell BP. Effect of active immunization against testosterone on plasma gonadotrophin concentrations, spermatogenic function, testicular blood flow, epididymis mass and mating behaviour in adult rams. J. Reprod Perth. 104(1), 17–26 (1995).
  • Abdennebi L, Coutre L, Gerbert D, Pajot E, Salesse R, Remy JJ. Generating FSH antagonists and agonists through immunization against FSH receptor N-terminal decapeptides. j Mal Endocrinol 22(2), 151–159 (1999).
  • Saxena BB, Clavio A, Singh M et al. Modulation of ovarian function in female dogs immunized with bovine luteinizing hormone receptor. Reprod. Domest. Anim. 37(1), 9–17 (2002).
  • Naz RK. Fertilization-related sperm antigens and their immunocontraceptive potentials. Am. J. Reprod. Iminunol 44 (1), 41–46 (2000).
  • Naz RK, Zhu X. Molecular cloning and sequencing of a novel cDNA encoding for a protein involved in human sperm function. Biochem. Biophys. Res. Commun. 284(4), 911–917 (2001).
  • Paterson M, Jennings ZA, Wilson MR, Aitken RJ. The contraceptive potential of ZP3 and ZP3 peptides in a primate model. Reprod Immunol 53(1–2), 99–107 (2002).
  • Pomering M, Jones RC, Holland MK, Blake AE, Beagley KW Restricted entry of IgG into male and female rabbit reproductive ducts following immunization with recombinant rabbit PH-20. Am. J. Repmd Immunol 47(3), 174–182 (2002).
  • Dunshea FR, Colantoni C, Howard K et al. Vaccination of boars with a GnRII vaccine(Improvac) eliminates boar taint and increases growth performance. j An/in. Sci. 79(10), 2524–2535 (2001).
  • Miller LA, Johns BE, Killian GJ. Immunocontraception of white-tailed deer with GnRII vaccine. Am. J. Reprod.Immunol 44(5), 266–274 (2000).
  • Thompson DL. Immunisation against GnRH in male species (comparative aspects). Artim. Repmd Li. 60–61,459-469 (2000).
  • Fayrer-Hosken RA, Grobler D,Van Altena JJ, Bertschinger HS, Kirkpatrick JF. Immunocontraception of African elephants. Nature 407(6801), 149 (2000).
  • Srivastava N, Santhanam R, Sheela P et al Evaluation of the immunocontraceptive potential of Eschericia coil — expressed recombinant dog ZP2 and ZP3 in a homologous animal model. Reproduction 123(6), 847–857 (2002).
  • Miller LA, Killian GJ. In search of the active PZP epitope in white-tailed deer immunocontraception. Vaccine 20 (21-22), 2735–2742 (2002).
  • Vanage GR, Mehta PB, Moodbidri SB, Iyer KS. Effect of immunization with synthetic peptide corresponding to region 1–17 of human seminal plasma inhibin on fertility of male rats. Azrh. Anchol 44(1), 11–21 (2000).
  • Bame JH, Dalton JC, Degelos SD. Effect of long-term immunization against inhibin on sperm output in bulls. Biol. Reprod 60(6), 1360–1366 (1999).
  • Shi F, Mochida K, Suzuki 0 etal. Development of embryos in superovulated guinea-pigs following active immunization against the inhibin a-subunit. Endocrinol j47(4), 451–459 (2000).
  • El-Halawani ME, Whiting SE, Silsby JL, Pitts GR, Chaiseha Y. Active immunization with vasoactive intestinal peptide in turkey hens. Fault. Sci.79(3), 349–354 (2000).
  • Grundker C, Volker P, Emons G. Antiproliferative signalling of LHRITinhuman endometrial and ovarian cancer cells through G-protein a (I)-mediated activation of phosphotyrosine phosphatase. Endocrinol 142(6), 2369–2380 (2001).
  • Lee CY, Ho J, Chow SN, Yasojima K, Schwab C, McGeer PL. Immunoidentfication of gonadotropin releasing hormone receptor in human sperm, pituitary and cancer cells. Am J. Repot" knmunol. 44 (3) 170–177 (2000).
  • Triozzi PL, Stevens VC. Human chorionic gonadotropin as a target for cancer vaccines. Oncol Rep. 6(1), 7–17 (1999).
  • Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL. Active specific immunotherapy with a13-human chorionic gonadotrophin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Gun. Cancer Res 8(7), 2044-2051 (2002).
  • Chiriva-Internati M, Wang Z, Salati E, Timmins P, Lim SH. Tumor vaccine for ovarian carcinoma targeting sperm protein 17. Cancer94(9), 2447–2453 (2002).
  • Scanlan MJ, Gordon CM, Williamson B et al Identification of cancer/testis genes by database mining and mRNA expression analysis. Int.j Cancer 98 (4), 485–492.
  • Paterson M, Wilson MR, Jennings ZA, van Duin M, Aitken RJ. Design and evaluation of a ZP3 peptide vaccine in a homologous primate model. Mal Hum. Reprod. 5(4), 342–352 (1999).
  • Gupta RK, Siber GR. Adjuvants for human vaccines — current status, problems and future prospects. Vaccine 13(14), 1263 —1276 (1995).
  • Ferro VA, Stimson WH. Investigation into suitable carrier molecules for use in anantiGnRH vaccine. Vaccine 16(11-12), 1095–1102 (1998).
  • Gupta A, Pal R, Ahlawat S, Bhatia P, Singh 0. Enhanced immunogenicity of a contraceptive vaccine using diverse synthetic carriers with permissible adjuvant. Vaccine 19(25–26), 3384–3389 (2001).
  • Yoshinaga K, Saxena DK, Oh-olca T, Tanii I, Toshimori K. Inhibition of mouse fertilization in vivo by intra-oviductal injection of an anti-equatorin monoclonal antibody. Reproduction 122(4), 649–655 (2001).
  • Ramsay, AJ, Ramshaw IA. Cytokine enhancement of immune responses important for immunocontraception. Reprod Fetid. Dev 9(1), 91–97 (1997).
  • Seferian PG, Martinez ML. Immune- stimulating activity of two new chitosan-containing adjuvant formulations. Vaccine 19 (6), 661–668 (2001).
  • Tast A, Love RJ, Clarke IJ, Evans G. Effects of active and passive gonadotrophin-releasing hormone immunization on recognition and establishment of pregnancy in pigs. Reprod Fetid. Dev 12(5-6), 277–282 (2000).
  • Clayton R, Cooke ID, Partridge LJ, Moore HD. A combinatorial phage-display library for the generation of specific Fab fragments recognizing human spermatazoa and inhibiting fertilizing capacity in vitm. Reprod 59(5), 1180–1186 (1998).
  • Adair E Monoclonal antibodies — magic bullets or a shot in the dark? Drug- Discov WorIc13(3), 53–60 (2002).
  • Howes E, Pascall JC, Engel W, Jones R. Interactions between mouse ZP2 glycoprotein and proacrosin; a mechanism for secondary binding of sperm to the zona pellucida during fertilization. J. Cell Sci 114,4127–4136 (2001).
  • Hasegawa A, Hamada Y, Shigeta M, Koyama K. Contraceptive potential of synthetic peptides of zona pellucida protein (ZPA).Reprod. humunol 53(1-2), 91–98 (2002).
  • Oonk HB, Turkstra JA, Schaaper WM etal. New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunoneutralization of GnRH. Vaccine 16(11-12), 1074–1082 (1998).
  • Ferro VA, Harvey MJA, Colston A, Stimson WH. Part II: influence of dimerization of a modified GnIZII peptidesequence on a male antifertility vaccine. Am.Reprod Imm. (2002) (In Press).
  • Lea IA, Widgren EE, ORand MG. Analysis of recombinant mouse zona pellucida protein 2 (ZP2) constructs for immunocontraception. Vaccine 20 (11–12), 1515–1523 (2002).
  • Williams CK. Development and use of virus-vectored immunocontraception. Reprod Perth. Dev 9(1), 169–178 (1997).
  • Gupta RK, Chang AC, Siber GR. Biodegradable polymer microsphers as vaccine adjuvants and delivery systems. Dev. Biol. Stand. 92,63–78 (1998).
  • Herr JC. Immunocontraceptive approaches. In: Contraceptive Research and Development. Harrison PF, Rosenfield A (Eds), National Academic Press, Washington, DC, USA, 125–165 (1996).
  • Ellis WV. In: New Vaccine Technologies.RW Ellis (Ed.), Landes Bioscience, TX, USA (2001).
  • Schrater AF Immunization to regulate fertility: biological and cultural frameworks. Soc. Li Med 41(5), 657–671 (1995).
  • Ryan EJ, Daly LM, Mills KH. Immunomodulators and delivery systems for vaccination by mucosal routes. Trends Biotechnol 19(8), 293–304 (2001).
  • Zhang H, Zhang J, Streisand JB. Oral mucosal delivery in clinical pharacokinetics and therapeutic applications. Clin. Pharmacokinet. 41(9), 661–680 (2002).
  • Bowersock TL, Martin S. Vaccine delivery to animals. Adv. Drug Deily. Rev 38(2), 167–194 (1999).
  • Mason HS, Warzecha H, Mor T, Arntzen CJ. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mal Med. 8(7), 324–329 (2002).
  • Morale MC, Gallo F, Tirolo C et al. Neuroendocrine-immune (NET) circuitry from neuron-glial interactions to function: Focus on gender and HPA—HPG interactions on early programming of the NET system. Immunol Cell Biol. 79(4), 400–417 (2001).
  • Burns KH, Matzuk MM. Minireview: Genetic models for the study of gonadotropin actions. Endocrinol 143(8), 2823–2835 (2002).
  • Ferro VA, Khan MA, Latimer VS, Brown D, Urbanski HF, Stimson WH. Immunoneutralisation of GnRH-I, without cross-reactivity to GnRH-II, in the development of a highly specific antifertility vaccine for clinical and veterinary use. J. Reprod. Immunol 51(2), 109–129 (2001).
  • Khan MAH, Ferro VA, Stimson WHS. Use of a highly specific monoclonal antibody against the central variable amino acid sequence of mammalian gonadotropin releasing hormone to evaluate GnIZII-I tissue distribution compared with GnIZII-Ibinding sites in adult male rats. Am. J. Reprod Immunol (2002) (In Press).
  • Rose NR. Immunologic hazards associated with vaccination of humans. j Autoimmun. 14(1), 11–3 (2000).
  • Edelman R. The development and use of vaccine adjuvants. Mal Biotech. 21(2), 129–148 (2002).
  • Ghosh S, Jackson DC. Antigenic and immunogenic properties of totally synthetic peptide-based antifertility vaccines. Int. Immunol 11(7), 1103–1110 (1999).
  • Russell MW Immunization for protection of the reproductive tract: a review. Am. J. Reprod Immunol 47(5), 265–268 (2002).
  • Glasier AF, Anakwe R, Everington D et al Would women trust their partners to use a male pill? Hum. Reprod 15(3), 646–649 (2000).
  • Martin CVV, Anderson RA, Cheng et al Potential impact of hormonal male contraception: crosscultural implications for development of novel preparations. Hum. Repmd 15(3), 637–645 (2000).

Websites

  • Naz RK, Vanek CM. Testis-specific proteins and their role in contraceptive vaccine development. Frontiers in Bioscience 3, e39-48 (1998). www.bioscience.org/1998/v3/e/naz /3.htm.
  • Hardon A: Contesting claims on the safety and acceptability of antifertility vaccines. www.hsph.harvard.eduOrganizations /healthnet/framel/framel.html [click on Contraception, under Reference and then choose New Methods for Women Immunocontraceptived.
  • International Symposium on Nonsurgical Contraceptive Methods for Pet Population Control, April 19–21,2002, Georgia, USA. www.vetmed.vt.edu/ACCD/index.html.
  • Information on a GnRII product (Starbiotech Inc). www.agwest.sk.ca/ bulletin/abb apr99.txt.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.